A study identified full-length PGRN and GRN E as activators of cathepsin D, but not cathepsin B or L. The diminished cathepsin D activity due to reduced PGRN expression contributed to FTD phenotypes and NCL pathology in GRN haploinsufficiency [89]. This evidence concerns the gene GRN and frontotemporal dementia.